Click for best price
Hepatitis B Therapeutics Market Size, Share 2022
This report contains market size and forecasts of Hepatitis B Therapeutics in Global, including the following market information:
Global Hepatitis B Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Therapeutics market was valued at 2563.9 million in 2021 and is projected to reach US$ 3125.7 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis B Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Therapeutics include GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Type, 2021 (%)
Hepatitis B Vaccine
Anti-viral Drugs
Global Hepatitis B Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hepatitis B Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Therapeutics Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Therapeutics Overall Market Size
2.1 Global Hepatitis B Therapeutics Market Size: 2021 VS 2028
2.2 Global Hepatitis B Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Therapeutics Players in Global Market
3.2 Top Global Hepatitis B Therapeutics Companies Ranked by Revenue
3.3 Global Hepatitis B Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis B Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Hepatitis B Vaccine
4.1.3 Anti-viral Drugs
4.2 By Type - Global Hepatitis B Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis B Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Hepatitis B Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis B Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis B Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis B Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis B Therapeutics Revenue, 2017-2028
6.3.2 US Hepatitis B Therapeutics Market Size, 2017-2028
6.3.3 Canada Hepatitis B Therapeutics Market Size, 2017-2028
6.3.4 Mexico Hepatitis B Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Therapeutics Revenue, 2017-2028
6.4.2 Germany Hepatitis B Therapeutics Market Size, 2017-2028
6.4.3 France Hepatitis B Therapeutics Market Size, 2017-2028
6.4.4 U.K. Hepatitis B Therapeutics Market Size, 2017-2028
6.4.5 Italy Hepatitis B Therapeutics Market Size, 2017-2028
6.4.6 Russia Hepatitis B Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis B Therapeutics Market Size, 2017-2028
6.4.8 Benelux Hepatitis B Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Therapeutics Revenue, 2017-2028
6.5.2 China Hepatitis B Therapeutics Market Size, 2017-2028
6.5.3 Japan Hepatitis B Therapeutics Market Size, 2017-2028
6.5.4 South Korea Hepatitis B Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis B Therapeutics Market Size, 2017-2028
6.5.6 India Hepatitis B Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis B Therapeutics Revenue, 2017-2028
6.6.2 Brazil Hepatitis B Therapeutics Market Size, 2017-2028
6.6.3 Argentina Hepatitis B Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, 2017-2028
6.7.2 Turkey Hepatitis B Therapeutics Market Size, 2017-2028
6.7.3 Israel Hepatitis B Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis B Therapeutics Market Size, 2017-2028
6.7.5 UAE Hepatitis B Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Hepatitis B Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Major Product Offerings
7.2.4 Bristol-Myers Squibb Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Novira Therapeutics
7.3.1 Novira Therapeutics Corporate Summary
7.3.2 Novira Therapeutics Business Overview
7.3.3 Novira Therapeutics Hepatitis B Therapeutics Major Product Offerings
7.3.4 Novira Therapeutics Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Novira Therapeutics Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis B Therapeutics Major Product Offerings
7.4.4 Johnson & Johnson Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Abivax
7.5.1 Abivax Corporate Summary
7.5.2 Abivax Business Overview
7.5.3 Abivax Hepatitis B Therapeutics Major Product Offerings
7.5.4 Abivax Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Abivax Key News
7.6 F. Hoffmann- La Roche
7.6.1 F. Hoffmann- La Roche Corporate Summary
7.6.2 F. Hoffmann- La Roche Business Overview
7.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Major Product Offerings
7.6.4 F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.6.5 F. Hoffmann- La Roche Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Hepatitis B Therapeutics Major Product Offerings
7.7.4 Novartis Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Novartis Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hepatitis B Therapeutics Major Product Offerings
7.8.4 Merck Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Therapeutics Market Drivers in Global Market
Table 3. Hepatitis B Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Therapeutics in Global Market
Table 5. Top Hepatitis B Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Hepatitis B Therapeutics Product Offerings
Table 32. GlaxoSmithKline Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Hepatitis B Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novira Therapeutics Corporate Summary
Table 37. Novira Therapeutics Hepatitis B Therapeutics Product Offerings
Table 38. Novira Therapeutics Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Hepatitis B Therapeutics Product Offerings
Table 41. Johnson & Johnson Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Abivax Corporate Summary
Table 43. Abivax Hepatitis B Therapeutics Product Offerings
Table 44. Abivax Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. F. Hoffmann- La Roche Corporate Summary
Table 46. F. Hoffmann- La Roche Hepatitis B Therapeutics Product Offerings
Table 47. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Hepatitis B Therapeutics Product Offerings
Table 50. Novartis Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Hepatitis B Therapeutics Product Offerings
Table 53. Merck Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis B Therapeutics Segment by Type in 2021
Figure 2. Hepatitis B Therapeutics Segment by Application in 2021
Figure 3. Global Hepatitis B Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2021
Figure 8. By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novira Therapeutics Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abivax Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
